Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane conductance regulator mediated diseases

US Patent 10980746 · Granted Apr 20, 2021

Estimated economic value: $482,858,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modulator of the Cystic Fibrosis Transmembrane Conductance Regulator, pharmaceut2025
Modulators of alpha-1 antitrypsin2025
Crystalline forms of CFTR modulators2025
Pharmaceutical composition and administrations thereof2025
Pharmaceutical composition and administrations thereof2025
Inhibitors of APOL1 and methods of using same2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024
Pharmaceutical compositions for the treatment of cystic fibrosis transmembrane c2024